echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Science Translational Medicine: mRNA vaccine enters a new field to prevent ticks from spreading diseases

    Science Translational Medicine: mRNA vaccine enters a new field to prevent ticks from spreading diseases

    • Last Update: 2021-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tick ​​is an important vector for spreading zoonotic diseases
    .


    As a strict blood-sucking arthropod, ticks can bite almost all animals on land, and have a long blood-sucking time, a large amount of blood, and a complicated life history


    Lyme disease is a natural foci disease caused by Borrelia burgdorferi infection.
    It is usually transmitted by the black-legged tick (I.
    scapularis) as a vector
    .


    In the United States alone, more than 40,000 cases of Lyme disease are reported each year, and the actual number of infections may be ten times higher


    The pandemic of the new crown pandemic has allowed mRNA vaccines to be approved quickly.
    With the large-scale application of mRNA new crown vaccines, people have seen the power of mRNA vaccines
    .


    Therefore, some researchers have begun to study the preventive potential of mRNA vaccines in preventing tick-borne diseases


    On November 17, 2021, researchers from Yale University School of Medicine published a research paper titled: mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent in Science Translational Medicine , which was also selected as the current issue.
    Cover paper
    .

    Science Translational Medicine mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent

    The study did not target specific tick-borne disease pathogens, but instead used lipid nanoparticles (LNP) to deliver mRNAs of 19 proteins (19ISP) found in the saliva of black-legged ticks to encourage the skin to bite the tick.
    The rapid response will limit the time for the tick to suck blood and infect the host, and it will also allow the host to quickly detect the tick bite, thereby preventing Lyme disease transmitted by the black-legged tick
    .

    This mRNA vaccine can provide protection in guinea pigs against Lyme disease infection caused by black-legged tick bites.
    Because the vaccine is for black-legged ticks, not specific pathogens, it can also combat other tick-borne diseases
    .

    Because ticks carry a large number of pathogens, tick bites can cause the spread of many diseases.
    Therefore, the research team did not target specific ticks-transmitted pathogens, but developed vaccines against ticks
    .

    The Erol Fikrig team of Yale University School of Medicine and the team of Drew Weissman of the University of Pennsylvania, the founder of the mRNA vaccine, conducted research on the black-legged tick that transmits Lyme disease.
    The saliva of the black-legged tick contains many types of proteins.
    Focus on 19 of them (19ISP)
    .


    Using the mRNA fragments that produce these proteins as the basis of the vaccine is the same strategy adopted in the new coronavirus mRNA vaccine


    Compared with guinea pigs that have not been vaccinated with mRNA vaccines, guinea pigs vaccinated with the vaccine quickly turn red at the site of the tick bite.
    If the tick is removed at this time, these vaccinated guinea pigs will not be infected with Lyme disease, but nearly 50% Of unvaccinated guinea pigs can become infected
    .

    When a tick bites and is not removed, guinea pigs vaccinated will not be infected with Lyme disease, and 60% of unvaccinated guinea pigs will be infected
    .

    When three ticks bite and are not removed, the vaccine's protective effect on guinea pigs will be weakened, but the ticks attached to the guinea pigs that have been vaccinated cannot eat actively and fall off more quickly
    .

    When a mosquito bites you, it will immediately feel itchy, reminding you to drive away the mosquito, but often you can't feel it when a tick bites, because the tick secretes a substance that numbs the skin
    .

    The research team said that this mRNA vaccine will not only allow the immune system to recognize ticks, thereby preventing Lyme disease
    .


    Moreover, the vaccine will make the tick bite site become red and itchy quickly, making the tick bite become as quickly detected as a mosquito bite, thereby further helping to remove the pathogen before it spreads


    The research team said that the mRNA vaccine may provide broader protection than a vaccine against a specific pathogen, and it can also be used in combination with traditional pathogen-based vaccines to further improve protection


    Erol Fikrig, the corresponding author of the paper, said that more research will be conducted to determine that the protein in tick saliva can be used to prevent tick-borne diseases, and eventually human experiments will be conducted to determine the efficacy of the vaccine


    Original source:

    Original source:

    ANDALEEB SAJID, et al.


    mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.